TNF Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$3,999,950 over the previous period. Total operating expenses were $17,123,052.
Profit Margin
| 2014 | 4.42M | -3.12M | -70.64% |
|---|---|---|---|
| 2015 | 2.11M | -9.31M | -440.27% |
| 2017 | 3.35M | -7.36M | -219.58% |
| 2020 | 0 | -17.58M | |
| 2023 | 0 | -3.99M |
TNFA Income Statement (2014 – 2023)
| 2023 | 2020 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 3.35M | 2.11M | 4.42M |
Cost of revenue | 0 | 29.45K | 2.57M | 1.18M | 1.43M |
Gross profit | 0 | -29.45K | 777.47K | 927.55K | 2.99M |
Operating exp. | |||||
Research and development | 7.86M | 7.96M | 1.26M | 1.40M | 916.30K |
Selling and marketing | 3.04M | -1.51M | 0 | 0 | 0 |
Total operating expenses | 17.12M | 12.25M | 7.39M | 10.14M | 6.19M |
Operating income | -17.12M | -12.28M | -6.61M | -9.21M | -3.20M |
Other income (expenses), net | 13.12M | 141 | -752.52K | -365.50K | 76.95K |
Income before tax | -3.99M | -12.15M | -7.36M | -9.58M | -3.12M |
Income tax expense | 0 | 5.42M | -4 | -269.34K | 0 |
Net income | -3.99M | -17.58M | -7.36M | -9.31M | -3.12M |
Earnings per share | |||||
Basic EPS | -5.33 | -149.57 | -8.93K | -20.86K | -7.62K |
Diluted EPS | -5.33 | -149.57 | -8.93K | -20.86K | -7.62K |